Skip to main content

Biorasis, Inc.


Date of Award

02.06.2018

Program

Improve Outcomes

Amount

$3,016,000.00

Term of Grant

24 months

Project Title

Early Feasibility Studies of the Glucowizzard in Care for T1D

Project Description

Funding to support the first human trial of Biorasis' implantable glucose biosensor, Glucowizzard™, and allow the device development to move forward with future clinical trials.